Ticker Details
Citius Pharmaceuticals, Inc. Citius Pharmaceuticals Inc is a specialty pharmaceutical company engaged in development and commercialization of therapeutic products for markets using patented or proprietary formulations and modified drug delivery technology.
IPO Date:	June 9, 2017
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$19.25M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.07 | 4.42%
Avg Daily Range (30 D):	$0.03 | 4.28%
Avg Daily Range (90 D):	$0.04 | 4.64%

Institutional Daily Volume
Avg Daily Volume:	1.51M
Avg Daily Volume (30 D):	.93M
Avg Daily Volume (90 D):	.68M

Trade Size
Avg Trade Size (Sh.):	393
Avg Trade Size (Sh.) (30 D):	382
Avg Trade Size (Sh.) (90 D):	364

Institutional Trades
Total Institutional Trades:	45
Avg Institutional Trade:	$2.78M
Avg Institutional Trade (30 D):	$6.8M
Avg Institutional Trade (90 D):	$6.8M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$6.35M
Avg Closing Trade (30 D):	$6.8M
Avg Closing Trade (90 D):	$6.8M
Avg Closing Volume:	149.91K

News

Feb 13, 2026 @ 1:00 PM Citius Pharmaceuticals, Inc. Announces First Repor... Source: Prnewswire

Feb 13, 2026 @ 1:00 PM Citius Oncology, Inc. Announces First Reported Rev... Source: Prnewswire

Dec 24, 2025 @ 2:04 PM Stock Market Today: Dow Jones, Nasdaq Futures Slip... Source: Rishabh Mishra

Dec 10, 2025 @ 9:30 PM Citius Oncology Announces Closing of $18 Million C... Source: Prnewswire

Dec 9, 2025 @ 1:30 PM Citius Oncology Announces $18 Million Concurrent R... Source: Prnewswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.95	$-.38	$-.11
Diluted EPS	$-.95	$-.38	$-.11
Revenue	$1.67M	$3.94M	$M
Gross Profit	$1.34M	$3.15M
Net Income / Loss	$-28.11M	$-9.39M	$-8.74M
Operating Income / Loss	$-32.19M	$-9.02M	$-8.44M
Cost of Revenue	$.33M	$.79M
Net Cash Flow	$-3.13M	$3.47M	$1M
PE Ratio

Splits
Nov 26, 2024	1:25
Jun 09, 2017	1:15
Sep 12, 2014	5:8